IL22RA2 and malignant colon neoplasm: By delivering the IL-22BP gene with a newly developed non-viral gene vector, DOTAP-modified mPEG-PCL micelles (DMP), the inhibitory efficacy of the DMP/IL-22BP complex on mouse colon cancer was examined via intraperitoneal administration.